| Tue, Nov 24, 2009 | | | Tuesday Options Recap at Seeking Alpha (Tue, Nov 24)
| | Mon, Nov 23, 2009 | | | JAZZ PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity EDGAR Online (Mon, Nov 23)
| | Fri, Nov 13, 2009 | | | 5 Stocks That Laugh at Wall Street at Motley Fool (Fri, Nov 13)
| | Wed, Nov 11, 2009 | | | JAZZ PHARMACEUTICALS INC Financials EDGAR Online Financials (Wed, Nov 11)
| | Tue, Nov 10, 2009 | | | Jazz Pharmaceuticals to Present at Investor Conference PR Newswire (Tue, Nov 10)
| | | JAZZ PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financi EDGAR Online (Tue, Nov 10)
| | Sun, Nov 8, 2009 | | | New Star Analyst Rankings for Jazz Pharmaceuticals, Inc. StarMine (Sun, Nov 8)
| | Fri, Nov 6, 2009 | | | JAZZ PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report EDGAR Online (Fri, Nov 6)
| | | HEADLINE STOCKS-U.S. small/midcap stocks on the move on Nov 6 at Reuters (Fri, Nov 6)
| | | Jazz Pharma 3Q loss narrows on Xyrem sales AP (Fri, Nov 6)
| | Thu, Nov 5, 2009 | | | Jazz Pharmaceuticals cuts Q3 loss, boosts revenue at bizjournals.com (Thu, Nov 5)
| | | JAZZ PHARMACEUTICALS INC Earnings Call scheduled for 5:00 pm ET today CCBN (Thu, Nov 5)
| | | JAZZ PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and EDGAR Online (Thu, Nov 5)
| | | Jazz Pharmaceuticals Announces Third Quarter 2009 Financial Results PR Newswire (Thu, Nov 5)
| | | Q3 2009 JAZZ PHARMACEUTICALS INC Earnings Release - Time Not Supplied CCBN (Thu, Nov 5)
| | Thu, Oct 29, 2009 | | | Jazz Pharmaceuticals to Announce Third Quarter Financial Results on November 5, 2009 PR Newswire (Thu, Oct 29)
| | | Trading Review for Jazz Pharmaceuticals Inc. Issued by Beacon Equity GlobeNewswire (Thu, Oct 29)
| | Fri, Oct 16, 2009 | | | Biotechs Back From The Dead at Forbes.com (Fri, Oct 16)
| | Thu, Oct 15, 2009 | | | [$$] Mild Profit-Taking at RealMoney by TheStreet.com (Thu, Oct 15)
| | Wed, Oct 14, 2009 | | | Data from Jazz Pharmaceuticals' First Phase III Study of Sodium Oxybate in Patients With Fibromyalgia to be Presented at Upcoming Conferences PR Newswire (Wed, Oct 14)
| Add JAZZ News to My Yahoo!:

| |
|